LSTA logo

Lisata Therapeutics (LSTA) Operating Expenses

Annual Operating Expenses

$25.71 M
-$31.89 M-55.37%

December 31, 2023


Summary


Performance

LSTA Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLSTAexpensesmetrics:

Quarterly Operating Expenses

$5.34 M
-$187.00 K-3.39%

September 30, 2024


Summary


Performance

LSTA Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLSTAexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

LSTA Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-55.4%-11.4%
3 y3 years+34.3%-11.4%
5 y5 years+51.3%-11.4%

LSTA Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-55.4%at low-85.8%at low
5 y5-year-55.4%+34.3%-85.8%+31.5%
alltimeall time-57.1%>+9999.0%-85.8%+4049.3%

Lisata Therapeutics Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$5.34 M(-3.4%)
Jun 2024
-
$5.52 M(-16.3%)
Mar 2024
-
$6.60 M(+9.6%)
Dec 2023
$25.71 M(-55.4%)
$6.03 M(+1.0%)
Sep 2023
-
$5.96 M(-13.3%)
Jun 2023
-
$6.88 M(+0.5%)
Mar 2023
-
$6.84 M(+4.6%)
Dec 2022
$57.60 M(+98.3%)
$6.54 M(-82.7%)
Sep 2022
-
$37.72 M(+461.3%)
Jun 2022
-
$6.72 M(+1.5%)
Mar 2022
-
$6.62 M(-3.3%)
Dec 2021
$29.05 M(+51.7%)
-
Dec 2021
-
$6.85 M(-1.7%)
Sep 2021
-
$6.97 M(-2.5%)
Jun 2021
-
$7.15 M(-11.6%)
Mar 2021
-
$8.09 M(+48.5%)
Dec 2020
$19.14 M(-4.7%)
$5.45 M(+1.8%)
Sep 2020
-
$5.35 M(+24.7%)
Jun 2020
-
$4.29 M(+5.8%)
Mar 2020
-
$4.06 M(-20.2%)
Dec 2019
$20.09 M(+18.3%)
$5.08 M(+0.2%)
Sep 2019
-
$5.07 M(-5.1%)
Jun 2019
-
$5.35 M(+16.4%)
Mar 2019
-
$4.59 M(+21.0%)
Dec 2018
$16.99 M(-38.4%)
$3.80 M(+0.9%)
Sep 2018
-
$3.76 M(-11.9%)
Jun 2018
-
$4.27 M(-17.3%)
Mar 2018
-
$5.16 M(-29.5%)
Dec 2017
$27.59 M(-6.5%)
$7.32 M(+19.4%)
Sep 2017
-
$6.13 M(-20.5%)
Jun 2017
-
$7.71 M(+19.9%)
Mar 2017
-
$6.43 M(+17.1%)
Dec 2016
$29.50 M(-45.3%)
$5.49 M(-4.1%)
Sep 2016
-
$5.73 M(-22.7%)
Jun 2016
-
$7.41 M(-40.0%)
Mar 2016
-
$12.33 M(+50.2%)
Dec 2015
$53.90 M(-10.2%)
$8.21 M(-28.3%)
Sep 2015
-
$11.46 M(-29.8%)
Jun 2015
-
$16.34 M(-8.7%)
Mar 2015
-
$17.89 M(+7.4%)
Dec 2014
$60.00 M(+55.7%)
$16.67 M(+1.8%)
Sep 2014
-
$16.36 M(+23.6%)
Jun 2014
-
$13.24 M(-3.5%)
Mar 2014
-
$13.73 M(+22.3%)
Dec 2013
$38.53 M(+17.6%)
$11.23 M(+11.8%)
Sep 2013
-
$10.04 M(+21.1%)
Jun 2013
-
$8.29 M(-7.5%)
Mar 2013
-
$8.96 M(+9.5%)
Dec 2012
$32.77 M(-7.5%)
$8.18 M(-6.7%)
Sep 2012
-
$8.78 M(+17.8%)
Jun 2012
-
$7.45 M(-10.9%)
Mar 2012
-
$8.36 M(-1.2%)
DateAnnualQuarterly
Dec 2011
$35.41 M(-8.0%)
$8.46 M(+12.5%)
Sep 2011
-
$7.52 M(-28.1%)
Jun 2011
-
$10.46 M(-15.6%)
Mar 2011
-
$12.39 M(+24.9%)
Dec 2010
$38.47 M(+38.8%)
$9.92 M(-9.7%)
Sep 2010
-
$10.99 M(+9.9%)
Jun 2010
-
$10.00 M(+31.7%)
Mar 2010
-
$7.59 M(-45.5%)
Dec 2009
$27.73 M(+198.6%)
$13.92 M(+91.6%)
Sep 2009
-
$7.26 M(+54.0%)
Jun 2009
-
$4.72 M(+151.3%)
Mar 2009
-
$1.88 M(-23.3%)
Dec 2008
$9.29 M(-12.8%)
$2.45 M(+26.3%)
Sep 2008
-
$1.94 M(-18.6%)
Jun 2008
-
$2.38 M(-5.7%)
Mar 2008
-
$2.52 M(+1.7%)
Dec 2007
$10.65 M(+125.8%)
$2.48 M(-42.6%)
Sep 2007
-
$4.33 M(+120.7%)
Jun 2007
-
$1.96 M(+4.7%)
Mar 2007
-
$1.87 M(+7.9%)
Dec 2006
$4.71 M(+192.6%)
$1.74 M(+73.6%)
Sep 2006
-
$999.80 K(-3.8%)
Jun 2006
-
$1.04 M(+10.7%)
Mar 2006
-
$939.20 K(+90.7%)
Dec 2005
$1.61 M(+8.2%)
$492.50 K(-9.6%)
Sep 2005
-
$544.60 K(+51.8%)
Jun 2005
-
$358.80 K(+66.5%)
Mar 2005
-
$215.50 K(-19.0%)
Dec 2004
$1.49 M(+62.7%)
$266.00 K(-36.4%)
Sep 2004
-
$418.40 K(+0.7%)
Jun 2004
-
$415.50 K(+6.8%)
Mar 2004
-
$389.10 K(+3.5%)
Dec 2003
$915.40 K(-21.8%)
$376.00 K(+86.8%)
Sep 2003
-
$201.30 K(-3.9%)
Jun 2003
-
$209.50 K(+62.9%)
Mar 2003
-
$128.60 K(-64.5%)
Dec 2002
$1.17 M(-28.8%)
$362.30 K(+57.0%)
Sep 2002
-
$230.80 K(+12.3%)
Jun 2002
-
$205.50 K(-44.7%)
Mar 2002
-
$371.40 K(-21.6%)
Dec 2001
$1.64 M(-34.6%)
$474.00 K(+22.4%)
Sep 2001
-
$387.40 K(+7.8%)
Jun 2001
-
$359.30 K(-14.9%)
Mar 2001
-
$422.20 K(-38.6%)
Dec 2000
$2.51 M(+145.5%)
$687.90 K(-34.0%)
Sep 2000
-
$1.04 M(+112.8%)
Jun 2000
-
$490.20 K(+63.6%)
Mar 2000
-
$299.70 K
Dec 1999
$1.02 M(+138.8%)
-
Dec 1998
$428.20 K(+93.2%)
-
Mar 1998
$221.60 K(-11.9%)
-
Mar 1997
$251.60 K(-2.1%)
-
Mar 1996
$257.10 K
-

FAQ

  • What is Lisata Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Lisata Therapeutics?
  • What is Lisata Therapeutics annual operating expenses year-on-year change?
  • What is Lisata Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Lisata Therapeutics?
  • What is Lisata Therapeutics quarterly operating expenses year-on-year change?

What is Lisata Therapeutics annual total operating expenses?

The current annual operating expenses of LSTA is $25.71 M

What is the all time high annual operating expenses for Lisata Therapeutics?

Lisata Therapeutics all-time high annual total operating expenses is $60.00 M

What is Lisata Therapeutics annual operating expenses year-on-year change?

Over the past year, LSTA annual total operating expenses has changed by -$31.89 M (-55.37%)

What is Lisata Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of LSTA is $5.34 M

What is the all time high quarterly operating expenses for Lisata Therapeutics?

Lisata Therapeutics all-time high quarterly total operating expenses is $37.72 M

What is Lisata Therapeutics quarterly operating expenses year-on-year change?

Over the past year, LSTA quarterly total operating expenses has changed by -$689.00 K (-11.44%)